Solvay, Ashland complete buys

3 May 2021 - 0 Submitted by Andrew Warmington

Two recent acquisitions that are both largely focused in the personal care arena were both completed almost simultaneously. Solvay completed the sale of its amphoteric surfactant business to OpenGate Capital, while Ashland finalised that of the personal care business of Schülke & Mayr from investment firm EQT.

Solvay’s deal covers three main production sites in University Park, Illinois, Genthin, Germany, and Halifax, UK, plus a tolling arrangement in Turkey. It also includes tolling and service agreements between Solvay and OpenGate, a Los Angeles-based private equity firm, “to ensure a seamless transition and minimal customer disruption”. The business has been renamed Verdant Specialty Solutions and its CEO is John Foley.

Solvay said that the sale “will generate additional resources for Solvay to invest in its strategic growth segments as part of its portfolio simplification journey”. Terms were not disclosed.

Ashland, meanwhile, paid €262.5 million for the Schülke & Mayr business, which mainly makes skin care products and preservatives. It said that this “strengthens Ashland’s consumer business portfolio and enhances the company’s specialty additives position while expanding the company’s biotechnology and microbiology technical competencies” and further aligning it with the ‘clean beauty’ trend.

The remainder of Schülke & Mayr remains under the ownership of EQT. This is active in its historic fields of antiseptics for wound care, disinfectants and medical skin care products and preservatives, with production taking place at three sites in Germany, France and Brazil.

Seqens commissioning UK diols plant

May 10, 2021/0

Seqens has revealed that it is commissioning a new plant at its site, which was formerly part of Chemoxy, in Billingham, north-east England. This will make diols such as 1,2-hexanediol, 2-ethylhexylglycerin and caprylyl glycol for use in cosmetic ingredients and hand sanitisers.

Renewable glycols JV in India

Mar 15, 2021/0

Clariant has agreed a strategic partnership to establish a 51-49% joint venture with India Glycols (IGL) in renewable ethylene oxide (EO) derivatives, subject to regulatory approvals. U.S. Bhartia has been designated chairman of the JV, which will employ about 200 people in India.

BASF in biosurfactant alliances

Mar 15, 2021/0

BASF has signed two distinct partnerships agreements to expand its position in biobased surfactants. These deals were made, the company said, in response to “the ever-increasing needs of consumers for sustainable, natural and biodegradable ingredients and actives”.

Libra invests in low-salt betaines

Feb 02, 2021/0

Libra Speciality Chemicals has broken ground on a multi-million-pound capital investment programme at its site in Irlam, UK. This will see new technology installed to produce novel low-salt betaines, while expanding the existing plant’s capacity from 32,000 to 50,000 tonnes/year.

Solvay in surfactants exit

Jan 14, 2021/0

Solvay Group has agreed to sell its North American and European amphoteric surfactant business to Los Angeles private equity firm OpenGate Capital. This is expected to close by the end of March, subject to consultation and regulatory approvals. Terms were not disclosed.

Azelis buys in Vietnam

Jan 06, 2021/0

Azelis has acquired a majority stake in two Vietnamese firms, MKVN Chemicals and Viet Chemicals, via their parent company Bellekimia Singapore. This continues a recent spree of acquisitions and investments in Asia for the global distributor.